← Evidence map

TrialClinical and translational science2026

Safety, Tolerability, and Pharmacokinetics of Single Doses of ABBV-916, an Anti-Amyloid Antibody, in Healthy Participants.

Sagar S Bachhav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41517979